The Nanomonitor measures biomarkers in patient blood faster, less expensive, and 10,000 times more sensitive than the current standard.
Pacific Nanoscience, Inc. (PacNano) is advancing a handheld point of care (POC) diagnostic product for the rapid, ultrasensitive detection of key biomarkers. The company is currently focused on troponin, which is the preferred biomarker used to diagnose heart attack. The Nanomonitor can measure troponin 13,000 times more sensitive than the current standard. Customers include physicians, hospitals, and patients.